Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial-Reference-Cited by-同舟云学术

Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial

Published:2020-04 Issue:10230 Volume:395 Page:1115-1125
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Deodhar Atul,Helliwell Philip S,Boehncke Wolf-Henning,Kollmeier Alexa P,Hsia Elizabeth C,Subramanian Ramanand A,Xu Xie L,Sheng Shihong,Agarwal Prasheen,Zhou Bei,Zhuang Yanli,Ritchlin Christopher T

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Etanercept and methotrexate as monotherapy or in combination for psoriatic arthritis: primary results from a randomized, controlled phase III trial;Mease;Arthritis Rheumatol,2019

2. Psoriatic arthritis;Ritchlin;N Engl J Med,2017

3. Switching biologics in the treatment of psoriatic arthritis;Merola;Semin Arthritis Rheum,2017

4. Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial;Nash;Lancet,2017

5. Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study;Fagerli;Ann Rheum Dis,2013

Cited by 259 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early Improvements with Guselkumab Associate with Sustained Control of Psoriatic Arthritis: Post hoc Analyses of Two Phase 3 Trials;Rheumatology and Therapy;2024-09-11

2. Shared Pathophysiology of Inflammatory Bowel Disease and Psoriasis: Unraveling the Connection;Cureus;2024-09-03

3. Newer Therapies in Rheumatology;Medical Clinics of North America;2024-09

4. Guselkumab Reduces Disease- and Mechanism-Related Biomarkers More Than Adalimumab in Patients with Psoriasis: A VOYAGE 1 Substudy;JID Innovations;2024-09

5. Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?;Autoimmunity Reviews;2024-09